Latest news

Thumbnail image for MHRA responds to consultation on Brexit no-deal proposals

MHRA responds to consultation on Brexit no-deal proposals

In advance of the UK leaving the European Union on 29 March 2019, the Medicines and Healthcare products Regulatory Agency (MHRA) has released a statement detailing its preparations for the event of a no-deal Brexit scenario.

4th January 2019

Thumbnail image for Sprycel combo gets FDA approval

Sprycel combo gets FDA approval

The US Food and Drug Administration has approved the new treatment Sprycel for children one year of age and older, facing a type of blood cancer known as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) when used in combination with chemotherapy.

3rd January 2019

Thumbnail image for Exonate fundraises £1.5 million

Exonate fundraises £1.5 million

Exonate has successfully fundraised £1.5 million to accelerate development of its lead product - an eye drop treatment for retinal neovascular diseases.

3rd January 2019

Thumbnail image for One in 20 GP appointments missed, costing £216m

One in 20 GP appointments missed, costing £216m

NHS England is urging patients to cancel appointments rather than just not show up, after news emerged that more than 15 million general practice appointments are being wasted each year because patients do not turn up and fail to warn surgeries in advance.

3rd January 2019

Thumbnail image for Does your team have what it takes to win?

Does your team have what it takes to win?

The PharmaTimes Clinical Researcher of the Year – The Americas in association with MAGI has a broad range of entry points for teams looking to compete among the very best in the industry.

2nd January 2019

Thumbnail image for NHS England to fund Actelion's Uptravi

NHS England to fund Actelion's Uptravi

Actelion Pharmaceuticals has announced that NHS patients in England, who have the rare, incurable and devastating disease pulmonary arterial hypertension (PAH), can now be treated with Uptravi.

2nd January 2019

Thumbnail image for New breast cancer protein discovered

New breast cancer protein discovered

Researchers from Cardiff University have discovered a protein driving aggressive breast cancer, which they say could be targeted for developing new and improved therapies.

2nd January 2019

Thumbnail image for Early access to Tecentriq combination granted through EAMS

Early access to Tecentriq combination granted through EAMS

UK patients with a form of advanced lung cancer will soon be able to access the immunotherapy drug Tecentriq in combination with Avastin, carboplatin and paclitaxel through the Early Access to Medicines Scheme (EAMS).

2nd January 2019

Thumbnail image for NHS to fund Afinitor for TSC-related epilepsy

NHS to fund Afinitor for TSC-related epilepsy

NHS England has announced that from April this year it will fund Novartis' Afinitor (everolimus) for patients living with Tuberous Sclerosis Complex (TSC)-related refractory epilepsy.

2nd January 2019

Thumbnail image for NICE recommends Lenvima for advanced liver cancer

NICE recommends Lenvima for advanced liver cancer

The National Institute for Health and Care excellence (NICE) has recommended Eisai and MSD’s Lenvima, a potentially life-extending treatment for adults with advanced liver cancer.

21st December 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download